JPMorgan keeps EUR 295 target for Sartorius stock

Published on 10/13/2026 at 09:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 3.11 percent to EUR 911.80 million. Sartorius stock costs EUR 251.95 on October 13, 2026, 0.42 percent below the Xetra close of EUR 253.00.

Key points in brief

JPMorgan kept its EUR 295.00 target and Overweight rating for Sartorius on October 12, 2026.
Second-quarter revenue rose 3.11 percent year over year to EUR 911.80 million, while earnings per share reached EUR 0.95.
Sartorius stock was trading at EUR 251.95 at Lang & Schwarz on October 13, 2026, 0.42 percent below the Xetra close.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern — Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius (ISIN DE0007165631) was trading at EUR 251.95 at Lang & Schwarz on October 13, 2026 at 9:34 a.m. CEST, 0.42 percent below the Xetra close of October 12, 2026 at EUR 253.00. FinanzNachrichten reported on October 12, 2026 that JPMorgan kept its Overweight rating and EUR 295.00 target ahead of third-quarter results.

Three dates frame the stock

On July 23, 2026, Sartorius reported second-quarter revenue of EUR 911.80 million, up 3.11 percent from EUR 884.30 million in the prior-year quarter, while earnings per share rose to EUR 0.95 from EUR 0.47, according to finanzen.net. Barclays then lifted its target from EUR 300.00 to EUR 310.00 on September 30, 2026, while retaining Overweight, as finanzen.ch reported. JPMorgan's October 12, 2026 update is the latest of the three, with the EUR 295.00 target unchanged.

What does JPMorgan expect?

JPMorgan expects Sartorius to slightly exceed market expectations in the third quarter, according to its October 12, 2026 note carried by FinanzNachrichten. Analyst Richard Vosser pointed to continued growth in consumables and equipment, making the upcoming report a test of whether the recovery is broadening beyond recurring products.

Next results date

Sartorius has scheduled its conference call for the nine-month 2026 results on October 22, 2026 at 1:00 p.m. CEST, according to the company's investor-relations page. The October 22 release will show whether the EUR 911.80 million second-quarter revenue base is translating into the earnings improvement anticipated by analysts.

Stock remains below yearly high

The Lang & Schwarz price of EUR 251.95 on October 13, 2026 at 9:34 a.m. CEST stood 0.42 percent below the Xetra close of October 12, 2026 at EUR 253.00. The quote was also EUR 19.95 below the 52-week high of EUR 271.90 and EUR 53.45 above the 52-week low of EUR 198.50, both as of October 13, 2026. The further course of trading is shown by the continuously updated real-time quote of Sartorius stock.